God, AIDS, Africa & HOPE

Reflections / Gedanken

POZ.com – Treatment News : New Therapy Shows Potential as an Anti-HIV Medication

New Therapy Shows Potential as an Anti-HIV Medication

A new antibody-based therapy prevents HIV from infecting CD4 cells and could become a potent antiviral treatment, according to an announcement by Peregrine Pharmaceuticals, which is developing the therapy. The new data are from a study published online ahead of print in The Journal of Experimental Medicine.

Peregrine’s experimental agent works by blocking phosphatidylserine (PS), a molecule normally found on the inside of cell membranes but can become exposed on the outside of the membranes of viruses and virally infected cells. Exposed PS, researchers believe, enables viruses such as HIV to evade immune recognition and dampens the body’s normal response to infection.

In previous experiments, researchers found that an anti-PS antibody called bavituximab had antiviral activity against a number of viruses as well as anti-cancer properties. That drug is in Phase I and II studies for HIV, hepatitis C virus (HCV) and several types of cancer.

In the most recent published experiment, Anthony Moody, MD, from Duke University in Durham, North Carolina, and his colleagues studied four antibodies targeted to PS. When the antibodies bound with PS on the surface of an immune cell called a monocyte, the researchers explained, the monocyte released chemical messengers called chemokines that blocked HIV from docking with CD4 cells.

“This publication is the latest in a series of presentations and publications that supports the potential of PS as a target in HIV infection and provides new insights into the unique mechanisms of action of our PS-targeting antibodies,” said Steven W. King, president and CEO of Peregrine. “While past studies have focused on the broad nature of the PS target, these new data reveal that some of these antibodies may also have highly specific effects.”

Moody and his colleagues found that the antibodies, in test tubes, blocked HIV infection of CD4 cells about 85 percent of the time. The specific area on the CD4 cell where the chemokines blocked entry was the CCR5 receptor—which is the target of the antiretroviral drugs Selzentry (maraviroc) and vicriviroc, and which is the receptor used by most strains of HIV to infect cells.

Moreover, Barton Haynes, MD, director of the Duke Human Vaccine Institute and senior author of the study, commented, “These results indicate that targeting a host cell lipid such as PS as an anti-viral strategy is a promising concept of relevance to new therapeutic and possibly prophylactic innovations for HIV.”


POZ – POZ Magazine – POZ.com – Treatment News : New Therapy Shows Potential as an Anti-HIV Medication.

Filed under: HIV and AIDS, HIV Treatment, Medical and Research, , ,

HIV, Development and HOPE – thoughts of a Catholic priest

Being a Roman - Catholic priest and working in the fields of HIV and social development in Africa has its challenges. You will find stories and reflections about my work, about the church, South Africa and Africa, about politics and whatever triggers my interest. You are most welcome to leave a comment or to get in touch with me. Blogging means to initiate thoughts and discussions and for the writer to formulate what is loosely running around in the heart and mind in need of being sorted and spoken out.

Follow God, AIDS, Africa & HOPE on WordPress.com


You can share this blog in many ways..

Bookmark and Share

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 4,135 other subscribers

Translation – Deutsch? Française? Espanol? …

The translation button is located on each single blog page, Copy the text, click the button and paste it for instant translation:
Website Translation Widget

or for the translation of the front page:

* Click for Translation


© Rev Fr Stefan Hippler and HIV, AIDS and HOPE.
Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Rev Fr Stefan Hippler and HIV, AIDS and HOPE with appropriate and specific direction to the original content.

This not withstanding the following applies:
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 3.0 Unported License.

%d bloggers like this: